Article Details
Retrieved on: 2024-09-12 22:54:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
MBX Biosciences, a Phase 2 biotech developing precision peptides for endocrine and metabolic diseases, raised $163 million by offering 10.
Article found on: www.renaissancecapital.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here